Insider Trading History of Markham Richard J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Markham Richard J since 2009. The trader's CIK number is 1362743. At the time of the last reporting, Markham Richard J was the Director of Nephrogenex, Inc.. (stock ticker symbol NRX). Also see all insider trading activities at Nephrogenex, Inc..

Note that in the past Markham Richard J also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Acura Pharmaceuticals, Inc (ACUR) by Markham Richard J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2010 ACUR 0 $0 10,923 $52,102 0 $0
2009 ACUR 0 $0 100,766 $713,912 0 $0

Yearly summary of insider trading at Nephrogenex, Inc. (NRX) by Markham Richard J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 NRX 790,000 $9,480,000 0 $0 0 $0


Insider trading activities at 2 companies by Markham Richard J:

1. Acura Pharmaceuticals, Inc (ACUR)

2. Nephrogenex, Inc. (NRX)

Table 1. Insider trading of Acura Pharmaceuticals, Inc (ACUR) by Markham Richard J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2010-03-05 ACUR Sale 10,923 4.77 52,102
2009-05-22 ACUR Sale 5,800 7.50 43,500
2009-05-26 ACUR Sale 10,000 7.38 73,800
2009-05-20 ACUR Sale 6,000 7.34 44,040
2009-05-15 ACUR Sale 1,338 7.04 9,419
2009-05-13 ACUR Sale 7,028 7.05 49,547
2009-05-07 ACUR Sale 12,900 6.91 89,139
2009-05-08 ACUR Sale 10,600 6.93 73,458
2009-05-06 ACUR Sale 12,100 6.79 82,159
2009-03-24 ACUR Sale 35,000 7.11 248,850

Table 2. Insider trading of Nephrogenex, Inc. (NRX) by Markham Richard J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-02-14 NRX Buy 790,000 12.00 9,480,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Markham Richard J (Director of Nephrogenex, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.